Huijin Zhao

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University

发表论文 20 篇 · 总被引 396 次 · h-index 10

代表论文

• MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells (2019 · Molecular Cancer · 被引 134)
• The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia (2016 · Blood · 被引 72)
• Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma (2018 · Medicine · 被引 57)
• MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells (2017 · Journal of Experimental & Clinical Cancer Research · 被引 25)
• All‐trans retinoic acid and arsenic combination therapy benefits low‐to‐intermediate‐risk patients with newly diagnosed acute promyelocytic leukaemia: a long‐term follow‐up based on multivariate analysis (2015 · British Journal of Haematology · 被引 15)
• Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population (2009 · Annals of Hematology · 被引 15)